Suppr超能文献

信号素在心血管疾病中的作用:潜在的治疗靶点和新型生物标志物。

The role of semaphorins in cardiovascular diseases: Potential therapeutic targets and novel biomarkers.

机构信息

Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.

Cardiovascular Research Institute, Wuhan University, Wuhan, China.

出版信息

FASEB J. 2022 Oct;36(10):e22509. doi: 10.1096/fj.202200844R.

Abstract

Semaphorins (Semas), which belongs to the axonal guidance molecules, include 8 classes and could affect axon growth in the nervous system. Recently, semaphorins were found to regulate other pathophysiological processes, such as immune response, oncogenesis, tumor angiogenesis, and bone homeostasis, through binding with their plexin and neuropilin receptors. In this review, we summarized the detailed role of semaphorins and their receptors in the pathological progression of various cardiovascular diseases (CVDs), highlighting that semaphorins may be potential therapeutic targets and novel biomarkers for CVDs.

摘要

信号素(Semaphorins,Semas)属于轴突导向分子,包括 8 个类别,可影响神经系统中的轴突生长。最近发现信号素通过与它们的神经丛蛋白和神经纤毛蛋白受体结合,调节免疫反应、肿瘤发生、肿瘤血管生成和骨内稳态等其他病理生理过程。在这篇综述中,我们总结了信号素及其受体在各种心血管疾病(CVDs)病理进展中的详细作用,强调信号素可能是 CVDs 的潜在治疗靶点和新型生物标志物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验